title: Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging.
abstract: Current noninvasive tests for coronary artery disease detect atherosclerosis or regional ischemia. Global myocardial flow reserve is not routinely identified, although it may be an additional marker of disease development and progression.
  
  
  METHODS
  For the clinical work-up of suspected or known stable coronary artery disease, 275 individuals had undergone rest-dipyridamole (82)Rb myocardial perfusion imaging using PET. In addition to clinical measures of regional perfusion and function, an experimentally validated approach to quantify global myocardial flow reserve was used. Follow-up was obtained for 362 ± 277 d.
  
  
  RESULTS
  Myocardial blood flow and flow reserve showed significant correlation to systemic and cardiac hemodynamics and a weak association with risk factors such as age and history of hyperlipidemia. Flow reserve was expectedly lower in subjects with regional ischemia (1.70 ± 0.65 vs. 2.31 ± 0.97 in those without; P < 0.0001), but a wide range was observed in those without regional perfusion abnormalities. We used a composite endpoint of hard and soft events to determine that flow reserve below the median was predictive of adverse outcome in the overall population (P = 0.001) and in subjects with normal regional perfusion (n = 178; P = 0.036), whereas stress flow was predictive only in the overall population (P = 0.001). Age-adjusted multivariate analysis confirmed regional perfusion defects (relative hazard, 2.51; 95% confidence interval, 1.24-5.10; P = 0.009) and low global flow reserve (relative hazard, 2.93; 95% confidence interval, 1.30-6.65; P = 0.011) as independent predictors of cardiac events.
  
  
  CONCLUSIONS
  In clinical cardiac (82)Rb PET, globally impaired flow reserve is a relevant marker for predicting short-term cardiovascular events. It may be used for integration with currently established functional and morphologic test results and for guidance of preventive measures, especially in the absence of regional flow-limiting disease.
authors.affiliation: Division of Nuclear Medicine, Russell H. Morgan Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.
authors.forename: Kenji
authors.initials: K
authors.lastname: Fukushima
authors.forename: Mehrbod S
authors.initials: MS
authors.lastname: Javadi
authors.forename: Takahiro
authors.initials: T
authors.lastname: Higuchi
authors.forename: Riikka
authors.initials: R
authors.lastname: Lautamäki
authors.forename: Jennifer
authors.initials: J
authors.lastname: Merrill
authors.forename: Stephan G
authors.initials: SG
authors.lastname: Nekolla
authors.forename: Frank M
authors.initials: FM
authors.lastname: Bengel
mesh_terms: D003324:Coronary Artery Disease / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D005260:Female; D053805:Fractional Flow Reserve, Myocardial; D006801:Humans; D008297:Male; D008875:Middle Aged; D055414:Myocardial Perfusion Imaging; D049268:Positron-Emission Tomography; D011379:Prognosis; D012414:Rubidium Radioisotopes; D013997:Time Factors; D018754:Ventricular Dysfunction / Q000000981:diagnostic imaging / Q000503:physiopathology
chemical_list: D012414:Rubidium Radioisotopes